[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

Cryptosporidiosis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF CRYPTOSPORIDIOSIS PIPELINE REPORT INCLUDES Panorama of Cryptosporidiosis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Cushing's Syndrome R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF CUSHING'S SYNDROME PIPELINE REPORT INCLUDES Panorama of Cushing's Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Cushing's Syndrome Pipeline candidates across various development ...

August 2018 50 pages

Cytomegalovirus Infection (HHV 5) R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF CYTOMEGALOVIRUS INFECTION (HHV 5) PIPELINE REPORT INCLUDES Panorama of Cytomegalovirus Infection (HHV 5) pipeline markets including statistics on therapeutic drugs and companies involved Cytomegalovirus Infection (HHV 5) Pipeline candidates across ...

August 2018 140 pages

Deep Vein Thrombosis (DVT) R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF DEEP VEIN THROMBOSIS (DVT) PIPELINE REPORT INCLUDES Panorama of Deep Vein Thrombosis (DVT) pipeline markets including statistics on therapeutic drugs and companies involved Deep Vein Thrombosis (DVT) Pipeline candidates across ...

August 2018 30 pages

Degenerative Disc Disease R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DEGENERATIVE DISC DISEASE PIPELINE REPORT INCLUDES Panorama of Degenerative Disc Disease pipeline markets including statistics on therapeutic drugs and companies involved Degenerative Disc Disease Pipeline candidates across various development ...

August 2018 50 pages

Dengue Fever R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DENGUE FEVER PIPELINE REPORT INCLUDES Panorama of Dengue Fever pipeline markets including statistics on therapeutic drugs and companies involved Dengue Fever Pipeline candidates across various development ...

August 2018 130 pages

Dental Pain R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DENTAL PAIN PIPELINE REPORT INCLUDES Panorama of Dental Pain pipeline markets including statistics on therapeutic drugs and companies involved Dental Pain Pipeline candidates across various development ...

August 2018 30 pages

Dermatomycoses R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF DERMATOMYCOSES PIPELINE REPORT INCLUDES Panorama of Dermatomycoses pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 50 pages

Dermatomyositis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF DERMATOMYOSITIS PIPELINE REPORT INCLUDES Panorama of Dermatomyositis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 160 pages

Diabetic Foot Ulcers R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DIABETIC FOOT ULCERS PIPELINE REPORT INCLUDES Panorama of Diabetic Foot Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Foot Ulcers Pipeline candidates across various development ...

August 2018 110 pages

Diabetic Gastroparesis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DIABETIC GASTROPARESIS PIPELINE REPORT INCLUDES Panorama of Diabetic Gastroparesis pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Gastroparesis Pipeline candidates across various development ...

August 2018 50 pages

Diabetic Neuropathic Pain R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DIABETIC NEUROPATHIC PAIN PIPELINE REPORT INCLUDES Panorama of Diabetic Neuropathic Pain pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Neuropathic Pain Pipeline candidates across various development ...

August 2018 80 pages

Diabetic Neuropathy R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DIABETIC NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Diabetic Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Neuropathy Pipeline candidates across various development ...

August 2018 80 pages

Diabetic Peripheral Neuropathy R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DIABETIC PERIPHERAL NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Diabetic Peripheral Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Peripheral Neuropathy Pipeline candidates across various development ...

August 2018 60 pages

Diarrhea R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF DIARRHEA PIPELINE REPORT INCLUDES Panorama of Diarrhea pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 120 pages

Dilated Cardiomyopathy R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DILATED CARDIOMYOPATHY PIPELINE REPORT INCLUDES Panorama of Dilated Cardiomyopathy pipeline markets including statistics on therapeutic drugs and companies involved Dilated Cardiomyopathy Pipeline candidates across various development ...

August 2018 50 pages

Diphtheria R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF DIPHTHERIA PIPELINE REPORT INCLUDES Panorama of Diphtheria pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 60 pages

Down Syndrome R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DOWN SYNDROME PIPELINE REPORT INCLUDES Panorama of Down Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Down Syndrome Pipeline candidates across various development ...

August 2018 50 pages

Dravet Syndrome R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DRAVET SYNDROME PIPELINE REPORT INCLUDES Panorama of Dravet Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Dravet Syndrome Pipeline candidates across various development ...

August 2018 60 pages

Drug Addiction R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... ready to use format. SCOPE OF DRUG ADDICTION PIPELINE REPORT INCLUDES Panorama of Drug Addiction pipeline markets including statistics on therapeutic drugs and companies involved Drug Addiction Pipeline candidates across various development ...

August 2018 130 pages

Dupuytren Contracture R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF DUPUYTREN CONTRACTURE PIPELINE REPORT INCLUDES Panorama of Dupuytren Contracture pipeline markets including statistics on therapeutic drugs and companies involved Dupuytren Contracture Pipeline candidates across various development ...

August 2018 20 pages

Dyskinesia R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF DYSKINESIA PIPELINE REPORT INCLUDES Panorama of Dyskinesia pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 130 pages

Dystonia R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF DYSTONIA PIPELINE REPORT INCLUDES Panorama of Dystonia pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 40 pages

Eastern Equine Encephalitis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF EASTERN EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Eastern Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Eastern Equine Encephalitis Pipeline candidates across various development ...

August 2018 30 pages

Emphysema R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF EMPHYSEMA PIPELINE REPORT INCLUDES Panorama of Emphysema pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 40 pages

Encephalitis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Encephalomyelitis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF ENCEPHALOMYELITIS PIPELINE REPORT INCLUDES Panorama of Encephalomyelitis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 40 pages

Encephalopathy R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF ENCEPHALOPATHY PIPELINE REPORT INCLUDES Panorama of Encephalopathy pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 60 pages

End Stage Renal Disease (ESRD) R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF END STAGE RENAL DISEASE (ESRD) PIPELINE REPORT INCLUDES Panorama of End Stage Renal Disease (ESRD) pipeline markets including statistics on therapeutic drugs and companies involved End Stage Renal Disease (ESRD) Pipeline candidates across ...

August 2018 40 pages

Endometriosis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF ENDOMETRIOSIS PIPELINE REPORT INCLUDES Panorama of Endometriosis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 110 pages

Enterocolitis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF ENTEROCOLITIS PIPELINE REPORT INCLUDES Panorama of Enterocolitis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Eosinophilic Esophagitis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF EOSINOPHILIC ESOPHAGITIS PIPELINE REPORT INCLUDES Panorama of Eosinophilic Esophagitis pipeline markets including statistics on therapeutic drugs and companies involved Eosinophilic Esophagitis Pipeline candidates across various development ...

August 2018 50 pages

Ependymoma R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF EPENDYMOMA PIPELINE REPORT INCLUDES Panorama of Ependymoma pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 120 pages

Epidermolysis Bullosa R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF EPIDERMOLYSIS BULLOSA PIPELINE REPORT INCLUDES Panorama of Epidermolysis Bullosa pipeline markets including statistics on therapeutic drugs and companies involved Epidermolysis Bullosa Pipeline candidates across various development ...

August 2018 90 pages

Epstein Barr Viral Infections R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF EPSTEIN BARR VIRAL INFECTIONS PIPELINE REPORT INCLUDES Panorama of Epstein Barr Viral Infections pipeline markets including statistics on therapeutic drugs and companies involved Epstein Barr Viral Infections Pipeline candidates across ...

August 2018 140 pages

Epstein–Barr Virus (HHV 4) Infections R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF EPSTEIN–BARR VIRUS (HHV 4) INFECTIONS PIPELINE REPORT INCLUDES Panorama of Epstein–Barr Virus (HHV 4) Infections pipeline markets including statistics on therapeutic drugs and companies involved Epstein–Barr Virus (HHV 4) Infections Pipeline candidates across ...

August 2018 140 pages

Equine Encephalitis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Equine Encephalitis Pipeline candidates across various development ...

August 2018 40 pages

Erectile Dysfunction R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ERECTILE DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Erectile Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Erectile Dysfunction Pipeline candidates across various development ...

August 2018 90 pages

Escherichia coli Infections R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ESCHERICHIA COLI INFECTIONS PIPELINE REPORT INCLUDES Panorama of Escherichia coli Infections pipeline markets including statistics on therapeutic drugs and companies involved Escherichia coli Infections Pipeline candidates across various development ...

August 2018 150 pages

Essential Thrombocythemia R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ESSENTIAL THROMBOCYTHEMIA PIPELINE REPORT INCLUDES Panorama of Essential Thrombocythemia pipeline markets including statistics on therapeutic drugs and companies involved Essential Thrombocythemia Pipeline candidates across various development ...

August 2018 70 pages

Essential Tremor R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ESSENTIAL TREMOR PIPELINE REPORT INCLUDES Panorama of Essential Tremor pipeline markets including statistics on therapeutic drugs and companies involved Essential Tremor Pipeline candidates across various development ...

August 2018 40 pages

Exocrine Pancreatic Insufficiency R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF EXOCRINE PANCREATIC INSUFFICIENCY PIPELINE REPORT INCLUDES Panorama of Exocrine Pancreatic Insufficiency pipeline markets including statistics on therapeutic drugs and companies involved Exocrine Pancreatic Insufficiency Pipeline candidates across various development ...

August 2018 40 pages

Fabry Disease R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF FABRY DISEASE PIPELINE REPORT INCLUDES Panorama of Fabry Disease pipeline markets including statistics on therapeutic drugs and companies involved Fabry Disease Pipeline candidates across various development ...

August 2018 70 pages

Familial Adenomatous Polyposis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF FAMILIAL ADENOMATOUS POLYPOSIS PIPELINE REPORT INCLUDES Panorama of Familial Adenomatous Polyposis pipeline markets including statistics on therapeutic drugs and companies involved Familial Adenomatous Polyposis Pipeline candidates across various development ...

August 2018 30 pages

Familial Amyloid Neuropathies R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF FAMILIAL AMYLOID NEUROPATHIES PIPELINE REPORT INCLUDES Panorama of Familial Amyloid Neuropathies pipeline markets including statistics on therapeutic drugs and companies involved Familial Amyloid Neuropathies Pipeline candidates across various development ...

August 2018 60 pages

Fanconi Anemia R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF FANCONI ANEMIA PIPELINE REPORT INCLUDES Panorama of Fanconi Anemia pipeline markets including statistics on therapeutic drugs and companies involved Fanconi Anemia Pipeline candidates across various development ...

August 2018 40 pages

Fatigue R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF FATIGUE PIPELINE REPORT INCLUDES Panorama of Fatigue pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Female Contraception R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF FEMALE CONTRACEPTION PIPELINE REPORT INCLUDES Panorama of Female Contraception pipeline markets including statistics on therapeutic drugs and companies involved Female Contraception Pipeline candidates across various development ...

August 2018 70 pages

Female Hypoactive Sexual Desire Disorder R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER PIPELINE REPORT INCLUDES Panorama of Female Hypoactive Sexual Desire Disorder pipeline markets including statistics on therapeutic drugs and companies involved Female Hypoactive Sexual Desire Disorder Pipeline candidates across ...

August 2018 40 pages

Female Sexual Dysfunction R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF FEMALE SEXUAL DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Female Sexual Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Female Sexual Dysfunction Pipeline candidates across various development ...

August 2018 50 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers